Progentos Therapeutics
Latest round
- Series A
Last raised
- May 2024
Total raised
- $69M
Investors
- 5
About Progentos Therapeutics
Founded in 2024 by co-founders Chris Loose and Sanjay Magavi and based in Massachusetts, US, Progentos Therapeutics offers research and manufactures medicines for chronic illnesses like multiple sclerosis. Progentos is developing small-molecule drugs that target oligodendrocyte progenitor cells, which are responsible for producing myelin and activating cells to promote myelin regeneration, potentially restoring function lost due to MS damage.
Who invested in Progentos Therapeutics
5 investors across 1 round
See all investors in Progentos Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 3, 2024
Amount
$69M
Investors
Questions about Progentos Therapeutics
Who invested in Progentos Therapeutics?
Progentos Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Progentos Therapeutics raised?
Progentos Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Progentos Therapeutics last raise money?
Progentos Therapeutics's most recent round on record is a Series A, in May 2024.
What does Progentos Therapeutics do?
Founded in 2024 by co-founders Chris Loose and Sanjay Magavi and based in Massachusetts, US, Progentos Therapeutics offers research and manufactures medicines for chronic illnesses like multiple sclerosis.
Where is Progentos Therapeutics headquartered?
Progentos Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Progentos Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Progentos Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Progentos Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.